Strategic $6 million capital infusion via warrant exercise underscores continued conviction in FIZE Medical's growth across leading ICUs worldwide. The proceeds will be deployed to accelerate ...
NEW YORK, March 17, 2026 /PRNewswire/ -- FIZE Medical is pleased to share that a clinical research abstract featuring data obtained using the FIZE kUO® platform has been accepted for oral presentation ...
NEW YORK, Feb. 19, 2026 /PRNewswire/ -- FIZE Medical, a medical technology company focused on smart fluid management in critical care, announced the appointment of Prof. John A. Kellum, MD, MCCM, to ...
About 50 percent of patients hospitalized with normal kidneys in ICUs will be discharged with some kidney damage at the end of their hospitalization. Furthermore, studies have shown that effective ...
Integrated with FIZE's AI-enabled algorithms, FIZE's fluid management technology allows real-time treatment adjustments to prevent long-term kidney damage and improve patient outcomes. The company's ...
Immediately following the horrific October 7 massacre, the people of Israel have come together to offer their support to those who need it. Whether donating money, food supplies, equipment, or one’s ...
MIAMI, May 4, 2020 /PRNewswire/ -- Rapha Capital Management, LLC (https://www.raphacap.com), an investment management firm located in Miami, Florida, through Rapha Capital Investment IX, LLC ("RCI IX" ...
FIZE-kUO® groundbreaking device, anchoring FIZE's fluid management platform technology, detects early signs of kidney deterioration Integrated with FIZE's AI-enabled algorithms, FIZE's fluid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results